Figure 2.
A: Severity of liver fibrosis (LSM) in patients with T2DM screened in the outpatient clinical setting, divided into four stages: mild (F1), moderate (F2), severe or precirrhosis (F3), and cirrhosis (F4). B: Proportion of patients with moderate-to-advanced fibrosis (≥F2) having elevated plasma AST or ALT levels. C: Proportion of patients with a low risk, indeterminate risk, or high risk of advanced liver fibrosis by the fibrosis diagnostic panel APRI score. Total number of patients: 561.
